Welcome to our dedicated page for Quantumcore news (Ticker: QNCRF), a resource for investors and traders seeking the latest updates and insights on Quantumcore stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quantumcore's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quantumcore's position in the market.
QuantumCore (CSE: QNCR, OTCQB: QNCRF, FSE: K1Y) has been approved to trade on the OTCQB Venture Market, operated by OTC Markets Group, and began trading under symbol QNCRF on July 20, 2026. The company views this U.S. listing as a key step in its capital markets strategy, aiming to increase visibility among U.S. investors, improve trading accessibility via U.S. brokerage platforms, and potentially enhance liquidity.
QuantumCore will maintain its listings on the Canadian Securities Exchange (QNCR) and Frankfurt Stock Exchange (K1Y). The company develops quantum computing infrastructure technologies focused on superconducting amplification, cryogenic signal processing, and advanced quantum hardware for next-generation quantum computers and quantum networks.
QuantumCore (CSE: QNCR, FSE: K1Y, OTC: QNCRF) reported that all matters at its July 20, 2026 annual general and special meeting were approved. Shareholders set the board size at five directors and elected Eugene Profis, Christopher Wilson, Matthew McGowan, Rory McGillis and David Marantz, each receiving 99.992% votes in favour.
Shareholders also approved appointing MNP LLP as auditor, with 99.992% of votes supporting the resolution. An omnibus incentive plan allowing awards of up to 20% of issued and outstanding common shares received 99.891% support. A special resolution to continue the company into Ontario under the Business Corporations Act (Ontario) was likewise approved with 99.891% of votes cast in favour.